StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) stock

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)

Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%

Bicycle Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Bicycle Therapeutics's total assets was $567.18M at Sep 30, 2026. For fiscal 2025 it was $717.60M, down 25.0% from the year before. The highest annual figure on record is $956.87M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$717.60M-25.0%
FY2024Dec 31, 2024$956.87M+60.7%
FY2023Dec 31, 2023$595.34M+45.0%
FY2022Dec 31, 2022$410.61M-14.4%
FY2021Dec 31, 2021$479.79M+197.7%
FY2020Dec 31, 2020$161.15M+46.2%
FY2019Dec 31, 2019$110.19M+35.0%
FY2018Dec 31, 2018$81.63M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$567.18M-25.8%
Q2 FY2026Jun 30, 2026$606.58M-27.1%
Q1 FY2026Mar 31, 2026$652.40M-26.2%
Q4 FY2025Dec 31, 2025$717.60M-25.0%
Q3 FY2025Sep 30, 2025$763.95M-23.4%
Q2 FY2025Jun 30, 2025$832.18M-21.3%
Q1 FY2025Mar 31, 2025$883.89M+61.5%
Q4 FY2024Dec 31, 2024$956.87M+60.7%
Q3 FY2024Sep 30, 2024$996.75M+56.1%
Q2 FY2024Jun 30, 2024$1.06B+132.8%
Q1 FY2024Mar 31, 2024$547.14M+27.6%
Q4 FY2023Dec 31, 2023$595.34M+45.0%
Q3 FY2023Sep 30, 2023$638.68M+53.1%
Q2 FY2023Jun 30, 2023$454.17M+2.0%
Q1 FY2023Mar 31, 2023$428.80M-6.7%
Q4 FY2022Dec 31, 2022$410.61M-14.4%
Q3 FY2022Sep 30, 2022$417.15M+48.3%
Q2 FY2022Jun 30, 2022$445.48M+97.1%
Q1 FY2022Mar 31, 2022$459.56M+105.3%
Q4 FY2021Dec 31, 2021$479.79M+197.7%
Q3 FY2021Sep 30, 2021$281.33M+65.4%
Q2 FY2021Jun 30, 2021$226.05M+90.6%
Q1 FY2021Mar 31, 2021$223.84M+73.1%
Q4 FY2020Dec 31, 2020$161.15M+46.2%
Q3 FY2020Sep 30, 2020$170.06M+46.5%
Q2 FY2020Jun 30, 2020$118.60M-6.1%
Q1 FY2020Mar 31, 2020$129.28M+58.4%
Q4 FY2019Dec 31, 2019$110.19M–
Q3 FY2019Sep 30, 2019$116.06M–
Q2 FY2019Jun 30, 2019$126.25M–
Q4 FY2018Dec 31, 2018$81.63M–

More Bicycle Therapeutics figures

See a number that looks wrong?